Custom Cutting Block Instrument vs Regular Instrumentation Total Knee Replacement (TKR)

September 30, 2021 updated by: Dr. Thomas Turgeon, Orthopaedic Innovation Centre

A Double-blinded, Randomized, Controlled Trial of Total Knee Replacement Using Custom Cutting Block Instrument vs Regular Instrumentation

To determine if the use of patient-specific custom cutting blocks for implantation of total knee components results in improved limb alignment and component positioning compared to regular instrumentation.

Study Overview

Status

Completed

Detailed Description

This is a randomized controlled trial. Patients will be randomized to have their knee implanted using either the patient-specific custom cutting blocks or the regular instrumentation system. Functional and radiographic outcomes will be assessed in a blinded fashion. The Smith and Nephew Legion Primary® total knee system will be used in both groups; this is an implant with a good long term track record based on the Genesis II design. All surgeons have used and are familiar with the regular instrumentation. They will be instructed in the use of the patient-specific custom cutting blocks prior to study initiation.

Study Type

Interventional

Enrollment (Actual)

54

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Manitoba
      • Winnipeg, Manitoba, Canada, R2K 3S8
        • Concordia Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Patient is male or female ages 18 and over.
  2. Patient is having primary total knee replacement
  3. Patient is willing to sign the informed consent and to come for all study visits.

Exclusion Criteria:

  1. Deformity of the femur preventing use of the intra-medullary guide utilized in the regular instrumentation set.
  2. Necessity for the use of constrained implants. These types of implants have intra-medullary stems, therefore all bone cuts need to be referenced off intramedullary guides, making image guided bone cuts inappropriate.
  3. Patients undergoing knee replacement revision surgery. Theses types of implants also have stems, making the use of image guided bone cuts inappropriate for the same reasons.
  4. Patients scheduled for bilateral knee surgery (simultaneous or staged)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Custom Block Instrumentation
Patients-specific custom cutting blocks using the Smith and Nephew Visionaire system
Custom cutting block using MRI to create patient specific instrumentations
Active Comparator: Traditional Instrumentation
Traditional cutting methods for Total Knee Replacement
Traditional cutting method

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Radiographic Alignment
Time Frame: 8 Weeks
Using 3 foot standing film
8 Weeks
Number of HKA Angle Outliers
Time Frame: 8 Weeks
The angle formed between the mechanical axes of the femur and tibia create the hip-knee-ankle (HKA) angle.
8 Weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
EuroQol (EQ) Five Dimension (5D) Survey
Time Frame: Preoperative, 1 and 2 years
Evaluate change from preoperative baseline to 1 and 2 year post operative in functional outcomes assessments using the EQ-5D (patient reported). The digits for the five dimensions can be combined into a 5-digit number that describes the patient's health state, this health state is range from 0 to 1.0. Higher scores indicate improved quality of life within each dimension.
Preoperative, 1 and 2 years
Oxford Knee Score
Time Frame: Preoperative, 1 and 2 years
Evaluate change from preoperative baseline to 1 and 2 year post operative in functional outcomes assessments using the Oxford 12 scores (patient reported). The score ranges from 0 to 48 with higher scores indicating improved function and less pain.
Preoperative, 1 and 2 years
Pain Catastrophizing Scale (PCS) Score
Time Frame: Preoperative, 1 and 2 years
Evaluate change from preoperative baseline to 1 and 2 year post operative in functional outcomes assessments using the PCS (patient reported). The total score ranges from 0 to 52 with higher scores indicating greater pain catastrophizing. Sub-scales will not be used in this study.
Preoperative, 1 and 2 years
Hip Pain
Time Frame: Preoperative, 1 and 2 years
Evaluate change from preoperative baseline to 1 and 2 year post operative in functional outcomes assessments using the Pain Visual Analog Scale (VAS). The scale is from 0 to 100, 0=no pain and at 100= worst pain. (patient reported).
Preoperative, 1 and 2 years
University of California Los Angeles (UCLA) Activity Score
Time Frame: Preoperative, 1 and 2 years
Evaluate change from preoperative baseline to 1 and 2 year post operative in activity level assessments using the UCLA Activity score (patient reported). The scale ranges from 1-10 with higher values associated with more intense activities.
Preoperative, 1 and 2 years
Patient Satisfaction
Time Frame: Preoperative, 1 and 2 years
Evaluate change from preoperative baseline to 1 and 2 year post operative in functional outcomes assessments using the Satisfaction Visual Analog Scale (VAS). The scale is from 0 to 100, 0=Not Satisfied and at 100=Satisfied. (patient reported).
Preoperative, 1 and 2 years

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Other Measure: Time
Time Frame: Intra-operative
Surgical and tourniquet time
Intra-operative
Blood Loss
Time Frame: Intra-operative
Blood loss during surgery >100ml (n)
Intra-operative
Length of Stay (LOS)
Time Frame: Peri-operative
Length of hospital stay
Peri-operative
Other Measures: Adverse Events
Time Frame: Peri-operative, intra-operative and post-operative

Peri-operative complications such as deep venous thrombosis, pulmonary emboli, wound complications and cardiac events.

Post-operative complication such as infection, loosening, etc.

Peri-operative, intra-operative and post-operative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Thomas Turgeon, MD MPH FRCSC, Orthopaedic Innovation Centre

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2011

Primary Completion (Actual)

May 1, 2017

Study Completion (Actual)

May 1, 2017

Study Registration Dates

First Submitted

December 13, 2017

First Submitted That Met QC Criteria

January 24, 2018

First Posted (Actual)

January 31, 2018

Study Record Updates

Last Update Posted (Actual)

October 4, 2021

Last Update Submitted That Met QC Criteria

September 30, 2021

Last Verified

September 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Osteoarthritis, Knee

Clinical Trials on Visionaire

Subscribe